TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive In Brief: Curran Moves From Fox Chase To Jefferson; Groundbreaking From UNC Lineberger Center December 2, 1994
TCL Archive New Creatinine Test Raises Questions About Accuracy Of Carboplatin Dosing October 8, 2010
